73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Study hints at why an aggressive form of brain cancer is hard to treat

Study hints at why an aggressive form of brain cancer is hard to treat

by Abbey Bigler,Broad Institute of MIT and HarvardAn illustration representing the cellular states of glioblastoma. Credit: Sébastien PerroudGlioblastoma is an incurable brain cancer that kills

Study hints at why an aggressive form of brain cancer is hard to treat

by Abbey Bigler,Broad Institute of MIT and HarvardAn illustration representing the cellular states of glioblastoma. Credit: Sébastien PerroudGlioblastoma is an incurable brain cancer that kills
Are fighter pilots at greater risk for prostate cancer? The Air Force is now asking

Are fighter pilots at greater risk for prostate cancer? The Air Force is now asking

by Tara Copp And Shirsho Dasgupta, Mcclatchy Washington BureauCredit: CC0 Public DomainThe Air Force has begun to look at whether there's increased risk for prostate cancer among its fighter pilot

Are fighter pilots at greater risk for prostate cancer? The Air Force is now asking

by Tara Copp And Shirsho Dasgupta, Mcclatchy Washington BureauCredit: CC0 Public DomainThe Air Force has begun to look at whether there's increased risk for prostate cancer among its fighter pilot
Barriers to early clinical trial access for adolescents and young adults still exist

Barriers to early clinical trial access for adolescents and young adults still exist

byEuropean Society for Medical OncologyYoung cancer patients at the crossroads of childhood and adulthood seem to be stuck in a treatment impasse. A study to be presented at the ESMO 2018 Congre

Barriers to early clinical trial access for adolescents and young adults still exist

byEuropean Society for Medical OncologyYoung cancer patients at the crossroads of childhood and adulthood seem to be stuck in a treatment impasse. A study to be presented at the ESMO 2018 Congre
Trial of cell-based therapy for high-risk lymphoma leads to FDA breakthrough designation

Trial of cell-based therapy for high-risk lymphoma leads to FDA breakthrough designation

by Krista Conger,Stanford UniversityScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDCAR-T cell therapy, which

Trial of cell-based therapy for high-risk lymphoma leads to FDA breakthrough designation

by Krista Conger,Stanford UniversityScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDCAR-T cell therapy, which
Exploring reasons for higher breast cancer risk among Caribbean women

Exploring reasons for higher breast cancer risk among Caribbean women

by Sylvester Comprehensive Cancer CenterSylvester researcher Sophia George, Ph.D., who was raised in the Caribbean country of Dominica. Credit: Sylvester Comprehensive Cancer CenterA new study from re

Exploring reasons for higher breast cancer risk among Caribbean women

by Sylvester Comprehensive Cancer CenterSylvester researcher Sophia George, Ph.D., who was raised in the Caribbean country of Dominica. Credit: Sylvester Comprehensive Cancer CenterA new study from re
Researchers map the effects of all potential changes in key cancer gene

Researchers map the effects of all potential changes in key cancer gene

byThe Francis Crick InstituteFunction scores capture fitness effects mediated at both the transcript and protein 457 level. Credit: Megan Buckley et alResearchers at the Francis Crick Institute

Researchers map the effects of all potential changes in key cancer gene

byThe Francis Crick InstituteFunction scores capture fitness effects mediated at both the transcript and protein 457 level. Credit: Megan Buckley et alResearchers at the Francis Crick Institute
How do we overcome treatment resistance in a sarcoma cancer with already limited treatment options?

How do we overcome treatment resistance in a sarcoma cancer with already limited treatment options?

by Elena Daviter-Nowell,Institute of Cancer ResearchHistopathology image of leiomyosarcoma. Credit:Wikimedia Commons, CC-BY-SA 4.0Leiomyosarcoma is a type of soft tissue sarcoma that is ha

How do we overcome treatment resistance in a sarcoma cancer with already limited treatment options?

by Elena Daviter-Nowell,Institute of Cancer ResearchHistopathology image of leiomyosarcoma. Credit:Wikimedia Commons, CC-BY-SA 4.0Leiomyosarcoma is a type of soft tissue sarcoma that is ha
Adjuvant nivolumab + ipilimumab lacks efficacy for localized renal cell carcinoma

Adjuvant nivolumab + ipilimumab lacks efficacy for localized renal cell carcinoma

Disease-free survival (DFS) does not differ with adjuvant nivolumab plus ipilimumab (NIVO+IPI) compared with placebo in patients with localized renal cell carcinoma (RCC) at high risk for postnephrect

Adjuvant nivolumab + ipilimumab lacks efficacy for localized renal cell carcinoma

Disease-free survival (DFS) does not differ with adjuvant nivolumab plus ipilimumab (NIVO+IPI) compared with placebo in patients with localized renal cell carcinoma (RCC) at high risk for postnephrect
Patient step counts predict lung cancer treatment outcomes, study finds

Patient step counts predict lung cancer treatment outcomes, study finds

byAmerican Society for Radiation OncologyCredit: CC0 Public DomainNumerous studies have shown that monitoring physical activity promotes better health—from reducing body mass index to watching f

Patient step counts predict lung cancer treatment outcomes, study finds

byAmerican Society for Radiation OncologyCredit: CC0 Public DomainNumerous studies have shown that monitoring physical activity promotes better health—from reducing body mass index to watching f
Access to high-cost targeted treatments varies for lung cancer

Access to high-cost targeted treatments varies for lung cancer

(HealthDay)—Not all patients have access to new, high-cost lung cancer drugs, according to a study recently published in theJournal of the National Cancer Institute.Cathy J. Bradley, Ph.D., from

Access to high-cost targeted treatments varies for lung cancer

(HealthDay)—Not all patients have access to new, high-cost lung cancer drugs, according to a study recently published in theJournal of the National Cancer Institute.Cathy J. Bradley, Ph.D., from
Could artificial sweeteners alter your microbiome?

Could artificial sweeteners alter your microbiome?

by Dennis ThompsonYou may think that artificial sweeteners can help you lose some weight, but a new study finds they are no good for your gut's microbiome.People who useaspartame(Equal

Could artificial sweeteners alter your microbiome?

by Dennis ThompsonYou may think that artificial sweeteners can help you lose some weight, but a new study finds they are no good for your gut's microbiome.People who useaspartame(Equal
Targeted screening could prevent one in six prostate cancer deaths

Targeted screening could prevent one in six prostate cancer deaths

byUniversity College LondonMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Nearly one in six deaths from prostate

Targeted screening could prevent one in six prostate cancer deaths

byUniversity College LondonMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Nearly one in six deaths from prostate